A carregar...

A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery

BACKGROUND: Predicting treatment response or survival of cancer patients remains challenging in immuno-oncology. Efforts to overcome these challenges focus, among others, on the discovery of new biomarkers. Despite advances in cellular and molecular approaches, only a limited number of candidate bio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Creemers, Jeroen H A, Lesterhuis, W Joost, Mehra, Niven, Gerritsen, Winald R, Figdor, Carl G, de Vries, I Jolanda M, Textor, Johannes
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8169479/
https://ncbi.nlm.nih.gov/pubmed/34059522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-002032
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!